- $1.63bn
- $3.68bn
- $1.76bn
- 37
- 96
- 40
- 59
Annual cashflow statement for Endo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -613 | -2,923 | -2,450 | 5,642 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 485 | 2,304 | 909 | -6,913 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 85.3 | 504 | 1,665 | 550 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 411 | 269 | 435 | -631 |
| Capital Expenditures | -77.9 | -99.7 | -94.3 | -56.7 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 18.4 | -33.4 | 44.5 | 25.3 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -59.5 | -133 | -49.8 | -31.5 |
| Financing Cash Flow Items | -32.8 | -324 | -605 | -294 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -105 | -514 | -605 | 111 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 246 | -382 | -219 | -554 |